Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600079.SS Stock Summary
Top 10 Correlated ETFs
600079.SS
In the News
600079.SS Financial details
Company Rating
Strong Buy
Market Cap
37.24B
Income
2.43B
Revenue
24.14B
Book val./share
9.99
Cash/share
3.07
Dividend
0.16
Dividend %
0.66%
Employees
16.07K
Optionable
No
Shortable
Yes
Earnings
24 Aug 2023
P/E
16.13
Forward P/E
-
PEG
5.62
P/S
1.64
P/B
2.42
P/C
7.88
P/FCF
41.87
Quick Ratio
1.08
Current Ratio
1.32
Debt / Equity
0.62
LT Debt / Equity
0.11
-
-
EPS (TTM)
1.48
EPS next Y
-
EPS next Q
-
EPS this Y
33.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.39%
Revenue Q/Q
-1.1%
EPS Q/Q
-
-
-
-
-
SMA20
4.35%
SMA50
-4%
SMA100
-11.11%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
16%
ROC
0.15%
Gross Margin
45%
Oper. Margin
14%
Profit Margin
10%
Payout
31%
Shs Outstand
1.63B
Shs Float
972.45M
-
-
-
-
Target Price
-
52W Range
15.92-28.92
52W High
-13.61%
52W Low
+61.27%
RSI
54
Rel Volume
1.34
Avg Volume
15.5M
Volume
20.82M
Perf Week
-2.3%
Perf Month
6.24%
Perf Quarter
-9.74%
Perf Half Y
-1.18%
-
-
-
-
Beta
0.793882
-
-
Volatility
0.6%, 0.86%
Prev Close
1.13%
Price
24.19
Change
1.51%
600079.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 14.52 | 15.25 | 15.01 | 12.95 | 13.85 | |
Net income per share | -1.82 | 0.91 | 1.19 | 1.15 | 1.54 | |
Operating cash flow per share | 0.46 | 1.4 | 1.44 | 1.37 | 1.51 | |
Free cash flow per share | -0.56 | 0.84 | 0.65 | 0.3 | -0.42 | |
Cash per share | 2.19 | 2.97 | 4.5 | 3.84 | 3.8 | |
Book value per share | 8.31 | 7 | 7.72 | 8.16 | 9.32 | |
Tangible book value per share | 5.61 | 5.03 | 7.2 | 7.51 | 8.81 | |
Share holders equity per share | 8.31 | 7 | 7.72 | 8.16 | 9.32 | |
Interest debt per share | 9.52 | 8.95 | 10.31 | 8.9 | 6.65 | |
Market cap | 12.77B | 19.63B | 46.68B | 35.74B | 38.54B | |
Enterprise value | 20.27B | 28.2B | 54.67B | 43.54B | 43.61B | |
P/E ratio | -5.38 | 14.92 | 28.42 | 19.66 | 15.51 | |
Price to sales ratio | 0.68 | 0.89 | 2.26 | 1.74 | 1.73 | |
POCF ratio | 21.17 | 9.63 | 23.47 | 16.4 | 15.79 | |
PFCF ratio | -17.45 | 16.13 | 52.41 | 75.11 | -57.32 | |
P/B Ratio | 1.18 | 1.93 | 4.39 | 2.76 | 2.56 | |
PTB ratio | 1.18 | 1.93 | 4.39 | 2.76 | 2.56 | |
EV to sales | 1.07 | 1.27 | 2.64 | 2.12 | 1.95 | |
Enterprise value over EBITDA | 6.68 | 8.15 | 14.95 | 10.57 | 9.39 | |
EV to operating cash flow | 33.61 | 13.84 | 27.49 | 19.98 | 17.86 | |
EV to free cash flow | -27.7 | 23.18 | 61.39 | 91.51 | -64.87 | |
Earnings yield | -0.19 | 0.07 | 0.04 | 0.05 | 0.06 | |
Free cash flow yield | -0.06 | 0.06 | 0.02 | 0.01 | -0.02 | |
Debt to equity | 1.08 | 1.19 | 1.26 | 1 | 0.68 | |
Debt to assets | 0.32 | 0.34 | 0.41 | 0.37 | 0.28 | |
Net debt to EBITDA | 2.47 | 2.48 | 2.18 | 1.89 | 1.09 | |
Current ratio | 1 | 1.08 | 1.28 | 1.17 | 1.28 | |
Interest coverage | -2.02 | 3.38 | 3.84 | 2.97 | 7.38 | |
Income quality | -0.31 | 1.51 | 1.15 | 1.2 | 0.79 | |
Dividend Yield | 0.08 | 0.05 | 0.02 | 0.02 | 0.02 | |
Payout ratio | -0.44 | 0.75 | 0.43 | 0.37 | 0.25 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.03 | -0.02 | 0.02 | |
Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.2 | 0.19 | 0.09 | 0.11 | 0.1 | |
Capex to operating cash flow | -2.21 | -0.4 | -0.55 | -0.78 | -1.28 | |
Capex to revenue | -0.07 | -0.04 | -0.05 | -0.08 | -0.14 | |
Capex to depreciation | -2.44 | -1.42 | -1.7 | -2.51 | -4.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.45 | 11.94 | 14.39 | 14.5 | 17.97 | |
ROIC | -0.09 | 0.1 | 0.1 | 0.11 | 0.12 | |
Return on tangible assets | -0.08 | 0.05 | 0.06 | 0.06 | 0.08 | |
Graham Net | -7.87 | -5.87 | -4.24 | -3.46 | -1.91 | |
Working capital | 58.78M | 1.3B | 3.75B | 2.59B | 4.29B | |
Tangible asset value | 7.3B | 7.3B | 9.91B | 11.91B | 14.22B | |
Net current asset value | -4.7B | -4.24B | -2.39B | -1.6B | 1.35B | |
Invested capital | 1.08 | 1.19 | 1.26 | 1 | 0.68 | |
Average receivables | 8.54B | 9.46B | 8.87B | 8.44B | 9.18B | |
Average payables | 2.99B | 3.42B | 2.94B | 2.54B | 3.07B | |
Average inventory | 3B | 3.38B | 3.07B | 2.89B | 3.27B | |
Days sales outstanding | 178.94 | 159.03 | 142.7 | 156.3 | 156.08 | |
Days payables outstanding | 107.01 | 94.1 | 72.88 | 83.37 | 99.79 | |
Days of inventory on hand | 104.62 | 94.18 | 80.81 | 97 | 98.97 | |
Receivables turnover | 2.04 | 2.3 | 2.56 | 2.34 | 2.34 | |
Payables turnover | 3.41 | 3.88 | 5.01 | 4.38 | 3.66 | |
Inventory turnover | 3.49 | 3.88 | 4.52 | 3.76 | 3.69 | |
ROE | -0.22 | 0.13 | 0.15 | 0.14 | 0.17 | |
Capex per share | -1.02 | -0.57 | -0.8 | -1.07 | -1.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 3.35 | 3.53 | 3.77 | 3.84 | 3.79 | |
Net income per share | 0.49 | 0.45 | 0.24 | 0.41 | 0.41 | |
Operating cash flow per share | 0.49 | 0.45 | 0.24 | 0.41 | 0.56 | |
Free cash flow per share | 0.27 | 0.21 | -0.05 | 0.16 | 0.26 | |
Cash per share | 2.53 | 3.1 | 3.79 | 2.55 | 3.07 | |
Book value per share | 8.85 | 9.33 | 9.31 | 9.7 | 9.99 | |
Tangible book value per share | 8.18 | 8.66 | 8.8 | 9.26 | 9.53 | |
Share holders equity per share | 8.85 | 9.33 | 9.31 | 9.7 | 9.99 | |
Interest debt per share | 7.57 | 6.42 | 6.4 | 5.64 | 6.25 | |
Market cap | 25.73B | 28.19B | 38.59B | 43.46B | 43.72B | |
Enterprise value | 34.39B | 34.61B | 43.66B | 49.28B | 49.69B | |
P/E ratio | 8.1 | 9.76 | 24.89 | 16.33 | 16.6 | |
Price to sales ratio | 4.77 | 4.97 | 6.35 | 6.98 | 7.1 | |
POCF ratio | 32.39 | 39.06 | 99.58 | 65.32 | 48.41 | |
PFCF ratio | 58.56 | 83.6 | -454.46 | 165.1 | 102.22 | |
P/B Ratio | 1.81 | 1.88 | 2.57 | 2.76 | 2.7 | |
PTB ratio | 1.81 | 1.88 | 2.57 | 2.76 | 2.7 | |
EV to sales | 6.38 | 6.1 | 7.18 | 7.92 | 8.07 | |
Enterprise value over EBITDA | 28.25 | 38.38 | 89.03 | 47.82 | 44.25 | |
EV to operating cash flow | 43.29 | 47.94 | 112.66 | 74.08 | 55.03 | |
EV to free cash flow | 78.26 | 102.63 | -514.18 | 187.24 | 116.2 | |
Earnings yield | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.01 | 0 | 0.01 | 0.01 | |
Debt to equity | 0.83 | 0.7 | 0.68 | 0.58 | 0.62 | |
Debt to assets | 0.33 | 0.3 | 0.28 | 0.26 | 0.27 | |
Net debt to EBITDA | 7.11 | 7.12 | 10.34 | 5.65 | 5.32 | |
Current ratio | 1.15 | 1.26 | 1.28 | 1.36 | 1.32 | |
Interest coverage | 2.51 | -7.85 | 4.34 | 10.73 | 12.56 | |
Income quality | 1 | 1 | 1 | 1 | 0 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0 | 0.01 | |
Payout ratio | 0.17 | 0.39 | 0.23 | 0.15 | 0.45 | |
Sales general and administrative to revenue | -0.11 | 0.22 | -0.1 | 0.06 | -0.02 | |
Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | |
Intangibles to total assets | 0.11 | 0.11 | 0.1 | 0.11 | 0.09 | |
Capex to operating cash flow | -0.45 | -0.53 | -1.22 | -0.6 | -0.53 | |
Capex to revenue | -0.07 | -0.07 | -0.08 | -0.06 | -0.08 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.92 | 9.7 | 7.09 | 9.46 | 9.55 | |
ROIC | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Return on tangible assets | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Graham Net | -3.39 | -1.89 | -1.91 | -1.7 | -1.74 | |
Working capital | 2.27B | 3.89B | 4.29B | 4.9B | 4.76B | |
Tangible asset value | 13.16B | 13.93B | 14.22B | 15.02B | 15.46B | |
Net current asset value | -1.25B | 1.23B | 1.35B | 1.9B | 1.81B | |
Invested capital | 0.83 | 0.7 | 0.68 | 0.58 | 0.62 | |
Average receivables | 10.22B | 10.14B | 9.97B | 10.19B | 11.05B | |
Average payables | 2.79B | 2.91B | 3.2B | 3.53B | 3.74B | |
Average inventory | 3.21B | 3.21B | 3.31B | 3.37B | 3.35B | |
Days sales outstanding | 165.13 | 164.57 | 141.34 | 156.53 | 164.87 | |
Days payables outstanding | 83.54 | 82.17 | 90.85 | 97.32 | 102.26 | |
Days of inventory on hand | 93.76 | 89.08 | 90.11 | 89.66 | 89.42 | |
Receivables turnover | 0.55 | 0.55 | 0.64 | 0.57 | 0.55 | |
Payables turnover | 1.08 | 1.1 | 0.99 | 0.92 | 0.88 | |
Inventory turnover | 0.96 | 1.01 | 1 | 1 | 1.01 | |
ROE | 0.06 | 0.05 | 0.03 | 0.04 | 0.04 | |
Capex per share | -0.22 | -0.24 | -0.29 | -0.25 | -0.29 |
600079.SS Frequently Asked Questions
What is Humanwell Healthcare (Group) Co.,Ltd. stock symbol ?
Humanwell Healthcare (Group) Co.,Ltd. is a CN stock and trading under the symbol 600079.SS
What is Humanwell Healthcare (Group) Co.,Ltd. stock quote today ?
Humanwell Healthcare (Group) Co.,Ltd. stock price is $24.19 today.
Is Humanwell Healthcare (Group) Co.,Ltd. stock public?
Yes, Humanwell Healthcare (Group) Co.,Ltd. is a publicly traded company.